Indonesia vs Iran: Share of E. coli infections resistant to cephalosporins
Indonesia
69.7%
in 2022
Iran
70.6%
in 2022
Indonesia rank
8th
Iran rank
7th
Share of E. coli infections resistant to cephalosporins over time
- Indonesia
- Iran
How they compare
Iran currently reports 70.6% against 69.7% in Indonesia, a difference of 0.9%.
The two have swapped places 3 times across 5 shared years of data; in 2018 it was Indonesia ahead.
Indonesia ranks 8th and Iran ranks 7th of 46 countries.
Indonesia has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Indonesia | Iran | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 71.0% | 67.9% | 3.1% | Indonesia |
| 2020s | 72.2% | 70.0% | 2.1% | Indonesia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher share of e. coli infections resistant to cephalosporins, Indonesia or Iran?
- Iran, at 70.6% against 69.7% in Indonesia as of 2022.
- What is the difference in share of e. coli infections resistant to cephalosporins between Indonesia and Iran?
- 0.9%, with Iran ahead.
- How many years of comparable data are there for Indonesia and Iran?
- 5 years are reported by both, from 2018 to 2022.
- How do Indonesia and Iran rank globally for share of e. coli infections resistant to cephalosporins?
- Indonesia ranks 8th and Iran ranks 7th of 46 countries.
- Where does this data come from?
- World Health Organization – processed by Our World in Data, published as Share of E. coli infections resistant to cephalosporins. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested (%).